Inmed Pharmaceuticals logo

Inmed Pharmaceuticals Share Price (NASDAQ: INM)

$2.2

0.02

(0.92%)

Last updated on

Check the interactive Inmed Pharmaceuticals Stock chart to analyse performance

Inmed Pharmaceuticals Inc Key Stats

Check Inmed Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.18
Open
$2.26
Market Capitalization
$4.4M
Today's Volume
$34.7K
Revenue TTM
$4.9M
EBITDA
$-7.9M
Earnings Per Share (EPS)
$-11.65
Profit Margin
-168.9%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-91.71%

Stock Returns calculator for Inmed Pharmaceuticals Stock including INR - Dollar returns

The Inmed Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Inmed Pharmaceuticals investment value today

Current value as on today

₹40,316

Returns

₹59,684

(-59.68%)

Returns from Inmed Pharmaceuticals Stock

₹64,968 (-64.97%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Inmed Pharmaceuticals Stock

-69%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Inmed Pharmaceuticals Stock from India on INDmoney has decreased by -69% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Inmed Pharmaceuticals Inc

  • Name

    Holdings %

  • UBS Group AG

    0.31%

  • Tower Research Capital LLC

    0.02%

  • SBI Securities Co Ltd

    0.02%

Analyst Recommendation on Inmed Pharmaceuticals Stock

Rating
Trend

Sell

    0%Buy

    37%Hold

    62%Sell

Based on 8 Wall street analysts offering stock ratings for Inmed Pharmaceuticals(by analysts ranked 0 to 5 stars)

Inmed Pharmaceuticals Share Price Target

What analysts predicted

Upside of 809.09%

Target:

$20.00

Current:

$2.20

Inmed Pharmaceuticals share price target is $20.00, a slight Upside of 809.09% compared to current price of $2.20 as per analysts' prediction.

Inmed Pharmaceuticals Stock Insights

  • Price Movement

    In the last 1 year, INM stock has moved down by -69.3%
  • Price Movement

    In the last 7 days, INM stock has moved up by 5.9%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 1.59M → 1.79M (in $), with an average increase of 11.0% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -3.70M → -3.02M (in $), with an average increase of 22.6% per quarter
  • INM vs NBIX (1 yr)

    In the last 1 year, Neurocrine Biosciences Inc. has given 9.9% return, outperforming this stock by 79.2%
  • INM vs HLN (3 yr)

    In the last 3 years, Haleon Plc Spon Ads has given 35.1% return, outperforming this stock by 133.4%
  • Price to Sales

    ForINM every $1 of sales, investors are willing to pay $0.3, whereas for Neurocrine Biosciences Inc., the investors are paying $5.6 for every $1 of sales.

Inmed Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Inmed Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Inmed Pharmaceuticals Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Inmed Pharmaceuticals Inc logo
-8.79%
-23.51%
-65.31%
-98.58%
-99.87%

About Inmed Pharmaceuticals Inc

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. It operates through two segments: InMed Pharma and BayMedica Commercial. The InMed Pharma segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with high unmet medical needs. The company's lead product is INM-755, a cannabinol topical skin cream, completed Phase 2 clinical trial for the treatment of epidermolysis bullosa. It also develops INM-089, which is a small molecule compound acting as a selective dual CB1 /CB2 agonist; and INM-900 for neurodegenerative diseases. In addition, the company offers IntegraSyn, an integrated biosynthesis-based manufacturing approach, for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.
Organization
Inmed Pharmaceuticals
Employees
13
CEO
Mr. Eric A. Adams B.S. Chem., M.I.B.
Industry
Health Technology

Key Management of Inmed Pharmaceuticals Inc

NameTitle
Mr. Eric A. Adams B.S. Chem., M.I.B.
President, CEO & Director
Ms. N. Netta Jagpal
CFO & Corporate Secretary
Mr. Michael Woudenberg P.Eng.
Chief Operating Officer
Ms. Alexandra Diane-Janet Mancini M.Sc.
Senior Vice President of Clinical & Regulatory Affairs
Dr. Eric Chih-Hsien Hsu Ph.D.
Senior Vice President of Preclinical Research & Development
Dr. Sazzad Hossain M.Sc., Ph.D.
Co-Founder
Colin Clancy
Senior Director of Investor Relations
Mr. Jerry P. Griffin
Vice President of Sales & Marketing
Dr. Shane A. Johnson Ph.D.
Senior VP & GM of BayMedica
Dr. Ado Muhammad
Senior Consultant of Medical Affairs

Important FAQs about investing in INM Stock from India :

What is Inmed Pharmaceuticals share price today?

Inmed Pharmaceuticals share price today is $2.20 as on at the close of the market. Inmed Pharmaceuticals share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Inmed Pharmaceuticals share?

Inmed Pharmaceuticals share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Inmed Pharmaceuticals stock price today i.e. is closed at $2.20, lower by 73.4% versus the 52 week high.

How to invest in Inmed Pharmaceuticals Stock (INM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Inmed Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inmed Pharmaceuticals Shares that will get you 0.6818 shares as per Inmed Pharmaceuticals share price of $2.20 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Inmed Pharmaceuticals Stock (INM) from India?

Indian investors can start investing in Inmed Pharmaceuticals (INM) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Inmed Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Inmed Pharmaceuticals share’s latest price of $2.20 as on August 30, 2025 at 1:29 am IST, you will get 4.5455 shares of Inmed Pharmaceuticals. Learn more about fractional shares .

What are the returns that Inmed Pharmaceuticals has given to Indian investors in the last 5 years?

Inmed Pharmaceuticals stock has given -99.87% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?